(Updated - November 6, 2018 6:28 AM EST)

Eli Lilly & Co. (NYSE: LLY) reported Q3 EPS of $1.39, $0.04 better than the analyst estimate of $1.35. Revenue for the quarter came in at $6.06 billion versus the consensus estimate of $6.05 billion.

GUIDANCE:

Eli Lilly & Co. sees FY2018 EPS of $5.55-$5.60, versus the consensus of $5.48. Revenue is seen at $24.3-$24.5 billion vs $24.4 billion expected.

For earnings history and earnings-related data on Eli Lilly & Co. (LLY) click here.